Interprofessional Medication Self-Management Program for Older Underserved Adults

Figures & data

Figure 1 Patient follow-up telephone call script.

Table 1 Patient Characteristics

Patients, n	50
Mean age, years (± SD)	67.1 (5.0)
Females, n (%)	39 (78.0)
Males, n (%)	11 (22.0)
Black or African American, n (%)	44 (88.0)
Other race or ethnicity, n (%)	4 (8.0)
White or Caucasian, n (%)	2 (4.0)
Mean systolic blood pressure, mm Hg (±SD)	159.8 (22.2)
Mean diastolic blood pressure, mm Hg (±SD)	75.0 (17.2)
Mean hemoglobin A1C, % (±SD)	9.7 (2.1)
Mean baseline weight, kg (±SD)	90.8 (23.5)
Mean body mass index, kg/m^2 (±SD)	33.5 (7.0)
Smokers, n (%)	9 (18.0)
Cardiovascular disease, n (%)	22 (41.0)
Chronic kidney disease, n (%)	12 (22.0)
Number of chronic medications, mean (±SD)	8.26 (2.67)

Table 2 Blood Pressure (BP) and Glycated Hemoglobin (A1C) Pre–Post Implementation

	1 Year Before	1 Year After	Mean Difference	95% Confidence Interval	P value
Total BP results, n	212	218	N/A
Number of BP results per patient, mean (±SD)	4.2 (0.9)	4.4 (0.8)
Mean systolic BP, mm Hg (±SD)	151.5 (12.9)	141.8 (12.0)	−9.70	−6.19 to −13.19	<0.001
Mean diastolic BP, mm Hg (±SD)	71.3 (12.0)	69.1 (11.2)	−2.20	−0.34 to 4.02	0.0121
Total A1C results, n	181	172	N/A
Number of A1C results per patient, mean (±SD)	3.6 (0.6)	3.5 (0.8)
Mean A1C, % (±SD)	9.6 (1.7)	8.6 (1.5)	−1.00	−0.49 to 1.39	<0.001

Table 3 Blood Pressure (BP) at Baseline and Each Follow-Up Visit

	Baseline	1-Month	3-Month	6-Month	9-Month	12-Month
Patients per visit, n	50	36	44	48	43	46
Mean systolic BP, mm Hg (±SD)	159.8 (22.2)	139.4 (18.0)	144.3 (25.0)	144.9 (22.5)	141.0 (16.3)	140.9 (15.0)
Mean difference^a, mm Hg	N/A	−20.40	−15.50	−14.90	−18.80	−18.90
P value^a	N/A	< 0.001	0.0003	<0.001	<0.001	<0.001
95% CI	N/A	−14.64 to −28.81	−7.41 to −22.95	−7.91 to −22.63	−12.89 to −25.89	−12.54 to −26.85
Mean diastolic BP, mm Hg (±SD)	74.8 (17.4)	68.1 (15.0)	71.3 (14.8)	69.9 (12.1)	67.8 (12.8)	67.4 (13.5)
Mean difference^a, mm Hg	N/A	−6.7	−3.5	−4.9	−7	−7.4
P value^a	N/A	<0.001	0.2513	0.0133	0.0023	0.003
95% CI	N/A	−3.89 to −13.14	−1.50 to 5.59	−1.16 to −9.43	−2.53 to −10.87	−2.89 to −13.23

Note: ^aCompared to baseline.

Abbreviation: CI, confidence interval.

Table 4 Hemoglobin (A1C) at Baseline and Each Follow-Up Visit

	Baseline	3-Month	6-Month	9-Month	12-Month
Patients per visit, n	50	40	47	44	43
Mean A1C, % (±SD)	9.7 (2.1)	8.8 (2.0)	8.9 (2.1)	8.3 (1.5)	8.3 (1.7)
Mean difference^a, %	N/A	−0.90	−0.80	−1.40	−1.40
P value^a	N/A	< 0.001	0.0024	< 0.001	< 0.001
95% CI	N/A	−0.39 to −1.33	−0.40 to −1.32	−0.82 to −1.96	−0.62 to −2.02

Note: ^aCompared to baseline.

Abbreviation: CI, confidence interval.

Figure 2 Systolic blood pressure trend.

Figure 3 Glycated hemoglobin (A1C) trend.